Monoclonal Antibodies Against Human Papillomavirus E6 and E7 Oncoproteins Inhibit Tumor Growth in Experimental Cervical Cancer
Nearly all cases of cervical cancer are initiated by persistent infection with high-risk strains of human papillomavirus (hr-HPV). When hr-HPV integrates into the host genome, the constitutive expression of oncogenic HPV proteins E6 and E7 function to disrupt p53 and retinoblastoma regulation of cel...
Main Authors: | Zewei Jiang, Joseph Albanese, Joshua Kesterson, Joshua Warrick, Rouzan Karabakhtsian, Ekaterina Dadachova, Rébécca Phaëton |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-10-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S193652331930018X |
Similar Items
-
E7 oncoprotein as a marker for persistence of human papillomavirus infection in patients with chronic cervicitis
by: T Y Pestrikova, et al.
Published: (2014-06-01) -
Preparation, Characterization and Diagnostic Valuation of Two Novel Anti-HPV16 E7 Oncoprotein Monoclonal Antibodies
by: Renjian Hu, et al.
Published: (2020-03-01) -
The production and characteristics of the monoclonal antibodies against TAL1 oncoprotein
by: Chang, Pei-Ching, et al.
Published: (1996) -
Cigarette Smoking Promotes Infection of Cervical Cells by High-Risk Human Papillomaviruses, but not Subsequent E7 Oncoprotein Expression
by: Kimon Chatzistamatiou, et al.
Published: (2018-01-01) -
Localisation of human papillomavirus 16 E7 oncoprotein changes with cell confluence.
by: Joanna Laurson, et al.
Published: (2011-01-01)